RECRUITING

Motivational Interviewing at Intake vs Intake as Usual on Client Engagement in Addiction Treatment

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This K23 study is an effectiveness-implementation hybrid type I design to determine the effectiveness of Motivational Interviewing at Intake (MII), relative to intake-as-usual on client engagement and mechanisms of engagement among adults seeking outpatient addiction treatment. We also will obtain personnel feedback on the feasibility of implementing MII into standard practice by having personnel from the addiction treatment study sites complete implementation climate measures before Motivational Interviewing (MI) training and post-clinical trial, as well as an individual interview on implementation feasibility post-trial.

Official Title

Adapting Intake Procedures to Improve Treatment Delivery in Addiction Treatment

Quick Facts

Study Start:2022-03-16
Study Completion:2026-12-01
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT05489068

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. Age 18 years or older
  2. Willing and able to provide informed consent
  3. Able to understand and follow study procedures
  4. Stable medical condition
  1. Pregnancy or breastfeeding
  2. Severe psychiatric disorders
  3. Active substance abuse
  4. Unstable medical conditions
  5. Inability to comply with study requirements

Contacts and Locations

Study Contact

Margo Hurlocker, PhD
CONTACT
(505) 596-0578
mhurlocker@unm.edu

Principal Investigator

Margo Hurlocker, PhD
PRINCIPAL_INVESTIGATOR
University of New Mexico

Study Locations (Sites)

Turning Point Recovery Center
Albuquerque, New Mexico, 87111
United States

Collaborators and Investigators

Sponsor: University of New Mexico

  • Margo Hurlocker, PhD, PRINCIPAL_INVESTIGATOR, University of New Mexico

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2022-03-16
Study Completion Date2026-12-01

Study Record Updates

Study Start Date2022-03-16
Study Completion Date2026-12-01

Terms related to this study

Additional Relevant MeSH Terms

  • Substance-Related Disorders
  • Treatment Adherence